Skip to Content

12 Results Found

  • Article
  • Open Access
4 Citations
4,832 Views
14 Pages

Identification of Spliceogenic Variants beyond Canonical GT-AG Splice Sites in Hereditary Cancer Genes

  • Vita Šetrajčič Dragoš,
  • Ksenija Strojnik,
  • Gašper Klančar,
  • Petra Škerl and ,
  • Vida Stegel,
  • Ana Blatnik,
  • Marta Banjac,
  • Mateja Krajc and
  • Srdjan Novaković
  • + 4 authors+ 0 author

Pathogenic/likely pathogenic variants in susceptibility genes that interrupt RNA splicing are a well-documented mechanism of hereditary cancer syndromes development. However, if RNA studies are not performed, most of the variants beyond the canonical...

(This article belongs to the Special Issue Mechanism and Regulation of Pre-mRNA Splicing 2.0)
  • Article
  • Open Access
2 Citations
4,085 Views
12 Pages

New Approach for Detection of Normal Alternative Splicing Events and Aberrant Spliceogenic Transcripts with Long-Range PCR and Deep RNA Sequencing

  • Vita Šetrajčič Dragoš,
  • Vida Stegel,
  • Ana Blatnik,
  • Gašper Klančar and ,
  • Mateja Krajc and
  • Srdjan Novaković
  • + 1 author+ 0 author

23 July 2021

RNA sequencing is a promising technique for detecting normal and aberrant RNA isoforms. Here, we present a new single-gene, straightforward 1-day hands-on protocol for detection of splicing alterations with deep RNA sequencing from blood. We have val...

(This article belongs to the Section Biochemistry and Molecular Biology)
  • Article
  • Open Access
26 Citations
6,952 Views
17 Pages

Role of Splicing Regulatory Elements and In Silico Tools Usage in the Identification of Deep Intronic Splicing Variants in Hereditary Breast/Ovarian Cancer Genes

  • Alejandro Moles-Fernández,
  • Joanna Domènech-Vivó,
  • Anna Tenés,
  • Judith Balmaña and ,
  • Orland Diez and
  • Sara Gutiérrez-Enríquez
  • + 1 author+ 0 author

3 July 2021

The contribution of deep intronic splice-altering variants to hereditary breast and ovarian cancer (HBOC) is unknown. Current computational in silico tools to predict spliceogenic variants leading to pseudoexons have limited efficiency. We assessed t...

(This article belongs to the Special Issue Genetic Variants Associated with Breast and Ovarian Cancer Risk)
  • Article
  • Open Access
14 Citations
4,283 Views
15 Pages

Minigene Splicing Assays Identify 20 Spliceogenic Variants of the Breast/Ovarian Cancer Susceptibility Gene RAD51C

  • Lara Sanoguera-Miralles,
  • Elena Bueno-Martínez,
  • Alberto Valenzuela-Palomo,
  • Ada Esteban-Sánchez and ,
  • Inés Llinares-Burguet,
  • Pedro Pérez-Segura,
  • Alicia García-Álvarez,
  • Miguel de la Hoya and
  • Eladio A. Velasco-Sampedro
  • + 4 authors+ 0 author

15 June 2022

RAD51C loss-of-function variants are associated with an increased risk of breast and ovarian cancers. Likewise, splicing disruptions are a frequent mechanism of gene inactivation. Taking advantage of a previous splicing-reporter minigene with exons 2...

(This article belongs to the Special Issue New Insights into Hereditary Cancer Syndromes)
  • Article
  • Open Access
3 Citations
4,557 Views
9 Pages

Quantifying BRCA1 and BRCA2 mRNA Isoform Expression Levels in Single Cells

  • Vanessa L. Lattimore,
  • John F. Pearson,
  • Arthur E. Morley-Bunker,
  • kConFab Investigators and ,
  • Amanda B. Spurdle,
  • Bridget A. Robinson,
  • Margaret J. Currie and
  • Logan C. Walker
  • + 3 authors+ 0 author

BRCA1 and BRCA2 spliceogenic variants are often associated with an elevated risk of breast and ovarian cancers. Analyses of BRCA1 and BRCA2 splicing patterns have traditionally used technologies that sample a population of cells but do not account fo...

(This article belongs to the Special Issue Pre-mRNA Splicing 2018)
  • Brief Report
  • Open Access
6 Citations
3,969 Views
6 Pages

A Family Case of Congenital Myasthenic Syndrome-22 Induced by Different Combinations of Molecular Causes in Siblings

  • Olga Shchagina,
  • Ludmila Bessonova,
  • Igor Bychkov,
  • Tatiana Beskorovainaya and
  • Aleksander Poliakov

19 July 2020

Congenital myasthenic syndrome-22 (CMS22, OMIM 616224) is a very rare recessive hereditary disorder. At the moment, ten CMS22 patients are described, with the disorder caused by nine different Loss-of-Function mutations and 14 gross deletions in the...

(This article belongs to the Section Human Genomics and Genetic Diseases)
  • Article
  • Open Access
5 Citations
2,977 Views
14 Pages

Splicing Dysregulation of Non-Canonical GC-5′ Splice Sites of Breast Cancer Susceptibility Genes ATM and PALB2

  • Inés Llinares-Burguet,
  • Lara Sanoguera-Miralles,
  • Alberto Valenzuela-Palomo,
  • Alicia García-Álvarez and ,
  • Elena Bueno-Martínez and
  • Eladio A. Velasco-Sampedro
  • + 1 author+ 0 author

22 October 2024

Background/Objectives: The non-canonical GC-5′ splice sites (5′ss) are the most common exception (~1%) to the classical GT/AG splicing rule. They constitute weak 5′ss and can be regulated by splicing factors, so they are especially...

(This article belongs to the Section Cancer Epidemiology and Prevention)
  • Article
  • Open Access
7 Citations
4,579 Views
11 Pages

Functional Analysis of the PCCA and PCCB Gene Variants Predicted to Affect Splicing

  • Igor Bychkov,
  • Artur Galushkin,
  • Alexandra Filatova,
  • Andrey Nekrasov and ,
  • Marina Kurkina,
  • Galina Baydakova,
  • Alexandra Ilyushkina,
  • Mikhail Skoblov and
  • Ekaterina Zakharova
  • + 4 authors+ 0 author

It is estimated that up to one-third of all variants causing inherited diseases affect splicing; however, their deleterious effects and roles in disease pathogenesis are often not fully characterized. Given their prevalence and the development of var...

(This article belongs to the Section Molecular Neurobiology)
  • Review
  • Open Access
423 Citations
40,402 Views
57 Pages

Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification

  • Rick Kamps,
  • Rita D. Brandão,
  • Bianca J. van den Bosch,
  • Aimee D. C. Paulussen and ,
  • Sofia Xanthoulea,
  • Marinus J. Blok and
  • Andrea Romano
  • + 2 authors+ 0 author

Next-generation sequencing (NGS) technology has expanded in the last decades with significant improvements in the reliability, sequencing chemistry, pipeline analyses, data interpretation and costs. Such advances make the use of NGS feasible in clini...

(This article belongs to the Special Issue Next-Generation Sequencing for Clinical Application)
  • Article
  • Open Access
10 Citations
5,180 Views
11 Pages

Application of Multigene Panels Testing for Hereditary Cancer Syndromes

  • Airat Bilyalov,
  • Sergey Nikolaev,
  • Leila Shigapova,
  • Igor Khatkov and ,
  • Anastasia Danishevich,
  • Ludmila Zhukova,
  • Sergei Smolin,
  • Marina Titova,
  • Tatyana Lisica and
  • Oleg Gusev
  • + 7 authors+ 2 authors

5 October 2022

Background: Approximately 5–10% of all cancers are associated with hereditary cancer predisposition syndromes (HCPS). Early identification of HCPS is facilitated by widespread use of next-generation sequencing (NGS) and brings significant benef...

(This article belongs to the Special Issue Prevention and Diagnosis of Gynaecological Cancers)
  • Article
  • Open Access
7 Citations
6,186 Views
18 Pages

Splicing Analysis of 16 PALB2 ClinVar Variants by Minigene Assays: Identification of Six Likely Pathogenic Variants

  • Alberto Valenzuela-Palomo,
  • Lara Sanoguera-Miralles,
  • Elena Bueno-Martínez,
  • Ada Esteban-Sánchez and ,
  • Inés Llinares-Burguet,
  • Alicia García-Álvarez,
  • Pedro Pérez-Segura,
  • Susana Gómez-Barrero,
  • Miguel de la Hoya and
  • Eladio A. Velasco-Sampedro
  • + 5 authors+ 0 author

19 September 2022

PALB2 loss-of-function variants are associated with significant increased risk of breast cancer as well as other types of tumors. Likewise, splicing disruptions are a common mechanism of disease susceptibility. Indeed, we previously showed, by minige...

(This article belongs to the Special Issue Updates on Breast Cancer)
  • Article
  • Open Access
19 Citations
5,229 Views
20 Pages

RAD51D Aberrant Splicing in Breast Cancer: Identification of Splicing Regulatory Elements and Minigene-Based Evaluation of 53 DNA Variants

  • Elena Bueno-Martínez,
  • Lara Sanoguera-Miralles,
  • Alberto Valenzuela-Palomo,
  • Víctor Lorca and ,
  • Alicia Gómez-Sanz,
  • Sara Carvalho,
  • Jamie Allen,
  • Mar Infante,
  • Pedro Pérez-Segura and
  • Eladio A. Velasco
  • + 10 authors+ 5 authors

7 June 2021

RAD51D loss-of-function variants increase lifetime risk of breast and ovarian cancer. Splicing disruption is a frequent pathogenic mechanism associated with variants in susceptibility genes. Herein, we have assessed the splicing and clinical impact o...

(This article belongs to the Special Issue Genetic Variants Associated with Breast and Ovarian Cancer Risk)